Authored By: Sarah
27 Dec 2021

Hematopoietic Stem Cells Transplantation (HSCT) Market | Leading Segments, Trends, Drivers and Challenges

Market Recovery and Growth Projections 2021-2025

Global hematopoietic stem cells transplantation (hsct) market is likely to post an incremental growth of $ 1.99 bn, accelerating at a CAGR of over 6% during the forecast period. This research provides a detailed analysis of the market segments and geographic landscape. It also offers insights into the various growth factors and challenges that are likely to have a negative impact on market growth. This thorough research will equip clients with the insights necessary to plan and strategize a post-pandemic recovery plan.


Request for Our Free Sample Report for detailed Insights


Hematopoietic Stem Cells Transplantation (HSCT) Market Size to Grow by $ 1.99 bn through 2021-2025 | Leading Segments and Market Trends

Hematopoietic Stem Cells Transplantation (HSCT) Market: Market Segments and Growth Forecasts

This research report will provide insights into the current market share of each segment along with growth projections for the next five years.

  • Market is segmented by Type (Autologous HSCT and Allogeneic HSCT) and Geography (North America, Europe, Asia, and ROW).
  • 40% of the market growth will originate from North America during the forecast period. This report provides an accurate prediction of the contribution of all the geographic segments to the growth of the Hematopoietic Stem Cells Transplantation (HSCT) Market size.

Hematopoietic Stem Cells Transplantation (HSCT) Market Size to Grow by $ 1.99 bn through 2021-2025 | Leading Segments and Market Trends

Hematopoietic Stem Cells Transplantation (HSCT) Market: Trends, Drivers, Challenges

The report also offers a detailed impact analysis of various trends, drivers, and challenges that are likely to influence the market growth during the forecast period. These insights will equip clients to design a growth strategy for their business and area of operations.

  • rising number of HSCT will be a significant factor in driving the growth of the Hematopoietic Stem Cells Transplantation (HSCT) Market.
  • availability of technologically advanced equipment will be instrumental in driving the market growth during the forecast period.
  • high cost of HSCT is a hurdle that needs to be crossed on the path to success.

Hematopoietic Stem Cells Transplantation (HSCT) Market: Vendor Analysis

  • The market is fragmented.
  • AllCells Corp., bluebird bio Inc., FUJIFILM Holdings Corp., Lineage Cell Therapeutics Inc., Lonza Group Ltd., MEDIPOST Co. Ltd., Merck and Co. Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and ThermoGenesis Holdings Inc. are some of the major market participants.
  • The unprecedented outbreak of COVID-19 in 2020 has had a significant impact on market segments had a ripple effect on various stakeholders. Our vendor analysis and insights will provide you with all the information required to make the most of the opportunities and plan business recovery and growth post the pandemic.

Key Areas Covered in our Report:

  • Hematopoietic Stem Cells Transplantation (HSCT) Market Split by Type
    • Autologous HSCT
    • Allogeneic HSCT
  • Hematopoietic Stem Cells Transplantation (HSCT) Market Split by Geography
    • North America
    • Europe
    • Asia
    • ROW

Customer landscape

  • Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • APAC - Market size and forecast 2020-2025
  • MEA - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • North America - Market size and forecast 2020-2025
  • South America - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Competitive scenario
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • AllCells Corp.
  • bluebird bio Inc.
  • FUJIFILM Holdings Corp.
  • Lineage Cell Therapeutics Inc.
  • Lonza Group Ltd.
  • MEDIPOST Co. Ltd.
  • Merck and Co. Inc.
  • Sanofi SA
  • Takeda Pharmaceutical Co. Ltd.
  • ThermoGenesis Holdings Inc.

For more insights into this market: Download a Free Sample Report. Our custom reports provide market insights at the global and regional level along with pipeline analysis of new product launches. It also provides a peek into the latest R&D along with an impact analysis of government regulations.

The report provides insights into the following FAQs:

  1. What is the market CAGR?
    The market will accelerate at a CAGR of over 6%.

     
  2. What is the incremental growth of the market?
    The market is expected to grow by $ 1.99 bn through 2021-2025.

     
  3. What is a key factor driving this market?
    rising number of HSCT will drive market growth over the forecast period.

     
  4. What are the key regions covered in this market research report?
    North America, Europe, Asia, and ROW are the key regions featured in this research report.

     
  5. Which is the leading geographic region for this market:
    40% growth will originate from North America

     
  6. Who are the leading market vendors?
    The leading vendors in this market are AllCells Corp., bluebird bio Inc., FUJIFILM Holdings Corp., Lineage Cell Therapeutics Inc., Lonza Group Ltd., MEDIPOST Co. Ltd., Merck and Co. Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and ThermoGenesis Holdings Inc.

     
  7. What are the market segments covered in this report?
    The market is segmented by Type (Autologous HSCT and Allogeneic HSCT) and Geography (North America, Europe, Asia, and ROW)

Hematopoietic Stem Cells Transplantation (HSCT) Market: Leading Regions and Market Trends

Geographical Segmentation and Growth Analysis

The hematopoietic stem cells transplantation (hsct) market is set to grow by $ 1.99 bn, accelerating at a CAGR of almost 6.16% during the forecast period. This research report analyses the growth trajectory of the market with a purview to prevalent market scenario, trends, and drivers. It also provides competitive bench-marking of the key market players and their product portfolios.


For more insights into our research and analysis: Request for our FREE Sample Report


Hematopoietic Stem Cells Transplantation (HSCT) Market: North America to lead market growth during the forecast period

  • Based on our Geographical Segmentation, North America is projected to contribute 40% of the market growth during the forecast period. This report provides an accurate prediction of the contribution of all the geographic segments to the growth of the hematopoietic stem cells transplantation (hsct) market size
  • One of the key drivers that is likely to drive market growth is the rising number of hsct. This report provides a detailed analysis of all the trends that are likely to influence the growth of individual segments within the market as well as the overall market.  These insights will equip clients with all the information they need to plan COVID-19 recovery and growth strategies.
  • The hematopoietic stem cells transplantation (hsct) market is segmented by Type (Autologous HSCT and Allogeneic HSCT) and Geography (North America, Europe, Asia, and ROW). Each segment and sub-segment is analyzed at depth to derive market insights and forecast growth projections.

Hematopoietic Stem Cells Transplantation (HSCT) Market Size to Grow by $ 1.99 bn through 2021-2025 | Leading Segments and Market Trends

Hematopoietic Stem Cells Transplantation (HSCT) Market: Key Competitors

Some of the leading vendors in this market are AllCells Corp., bluebird bio Inc., FUJIFILM Holdings Corp., Lineage Cell Therapeutics Inc., Lonza Group Ltd., MEDIPOST Co. Ltd., Merck and Co. Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and ThermoGenesis Holdings Inc.. The market is fragmented and the growth of the players in this market is dependent on several factors such as prevalent market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions.

For more insights on this market: Download a Free Sample Report

The report provides insights into the following FAQs:

  1. What is the market CAGR?
    The market is accelerate at a CAGR of 6.16%.
     
  2. What is the incremental growth of the market?
    The market is expected to grow by $ 1.99 bn through 2021-2025.
     
  3. What is a key factor driving this market?
    Rising number of HSCT will drive market growth over the forecast period.
     
  4. What are the key regions covered in this market research report?
    North America, Europe, Asia, and ROW are the key regions featured in this research report.
     
  5. Which is the leading geographic region for this market:
    40% growth will originate from North America
     
  6. Who are the leading market vendors?
    The leading vendors in this market are AllCells Corp., bluebird bio Inc., FUJIFILM Holdings Corp., Lineage Cell Therapeutics Inc., Lonza Group Ltd., MEDIPOST Co. Ltd., Merck and Co. Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and ThermoGenesis Holdings Inc.
     
  7. What are the market segments covered in this report?
    The market is segmented by Type (Autologous HSCT and Allogeneic HSCT) and Geography (North America, Europe, Asia, and ROW).

Market Segmentation by Type

    • Hematopoietic Stem Cells Transplantation (HSCT) Market Split by Type
      • Autologous HSCT
      • Allogeneic HSCT
    • Hematopoietic Stem Cells Transplantation (HSCT) Market Split by Geography
      • North America
      • Europe
      • Asia
      • ROW

Customer landscape

  • Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • APAC - Market size and forecast 2020-2025
  • MEA - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • North America - Market size and forecast 2020-2025
  • South America - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Competitive scenario
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • AllCells Corp.
  • bluebird bio Inc.
  • FUJIFILM Holdings Corp.
  • Lineage Cell Therapeutics Inc.
  • Lonza Group Ltd.
  • MEDIPOST Co. Ltd.
  • Merck and Co. Inc.
  • Sanofi SA
  • Takeda Pharmaceutical Co. Ltd.
  • ThermoGenesis Holdings Inc.

Read News Read Less
Interested in this report?
Get your sample now!
Technavio